raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:424970

Undifferentiated carcinoma of liver and intrahepatic biliary tract

Synonyms: Undifferentiated carcinoma of liver and IBT

Type
Disease
Group
Disorder
Inheritance
Not applicable
Age of onset
Adult
Status
active

Undifferentiated carcinoma of liver and intrahepatic biliary tract is an extremely rare epithelial tumor of the liver and biliary tract which presents heterogenous histological findings and not yet fully defined clinicopathological characterisitcs. Patients usually present with nonspecific signs and symptoms, such as abdominal pain, nausea, vomiting, anorexia, weight loss and/or jaundice. Invasive growth, high metastatic potential and a rapid clinical course are typically associated.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enUndifferentiated carcinoma of liver and intrahepatic biliary tractUndifferentiated carcinoma of liver and IBT
frCarcinome indifférencié du foie et des voies biliaires intrahépatiquesCarcinome indifférencié du foie et des VBIH
deUndifferenziertes Karzinom der Leber und intrahepatischen Gallengänge
esCarcinoma indiferenciado de hígado y vías biliares intrahepáticasCarcinoma indiferenciado de hígado y VBI
itCarcinoma indifferenziato del fegato e delle vie biliari intraepaticheCarcinoma non differenziato del fegato e delle VBI
nlOngedifferentieerd carcinoom van lever en intrahepatische galwegenOngedifferentieerd carcinoom van lever en IBT
ptCarcinoma hepático e do tracto biliar intra-hepático não diferenciadoCarcinoma indiferenciado do fígado e do TBIH
plNiezróżnicowany rak wątroby i wewnątrzwątrobowego przewodu żółciowegoNiezróżnicowany rak wątroby i IBT
csNediferencovaný karcinom jater a intrahepatálních žlučových cestNediferencovaný karcinom jater a IBT
ukНедиференційована карцинома печінки та внутрішньопечінкових жовчних шляхівНедиференційована карцинома печінки та IBT
zh肝和肝内胆道未分化癌肝未分化癌和IBT
trKaraciğer ve intrahepatik safra yollarının farklılaşmamış karsinomuFarklılaşmamış karaciğer karsinomu ve IBT

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10C22.0NTBTattributedvalidated
MONDO0018533Evalidated
UMLSC4749401Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

19 records
TypeClassValueAreaQualificationValidationSource
Annual incidence<1 / 1 000 0000.015 / 100 000EuropeValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence<1 / 1 000 0000.011 / 100 000AustriaValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence<1 / 1 000 0000.056 / 100 000Czech RepublicValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence<1 / 1 000 0000.046 / 100 000EstoniaValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence<1 / 1 000 0000.01 / 100 000FranceValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence<1 / 1 000 0000.02 / 100 000GermanyValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence<1 / 1 000 0000.03 / 100 000BulgariaValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence<1 / 1 000 0000.043 / 100 000IcelandValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence<1 / 1 000 0000.006 / 100 000IrelandValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence<1 / 1 000 0000.019 / 100 000ItalyValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence<1 / 1 000 0000.049 / 100 000LatviaValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence<1 / 1 000 0000.033 / 100 000LithuaniaValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence<1 / 1 000 0000.011 / 100 000NorwayValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence<1 / 1 000 0000.013 / 100 000PolandValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence<1 / 1 000 0000.016 / 100 000PortugalValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence<1 / 1 000 0000.098 / 100 000SlovakiaValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence<1 / 1 000 0000.015 / 100 000SpainValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence<1 / 1 000 0000.028 / 100 000SwitzerlandValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]
Annual incidence<1 / 1 000 0000.005 / 100 000United KingdomValue and classValidatedRARECARE surveillance of rare cancers in Europe[OTHER]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card